Does TINZAPARIN Cause Interstitial lung disease? 35 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Interstitial lung disease have been filed in association with TINZAPARIN. This represents 2.0% of all adverse event reports for TINZAPARIN.
35
Reports of Interstitial lung disease with TINZAPARIN
2.0%
of all TINZAPARIN reports
9
Deaths
25
Hospitalizations
How Dangerous Is Interstitial lung disease From TINZAPARIN?
Of the 35 reports, 9 (25.7%) resulted in death, 25 (71.4%) required hospitalization, and 14 (40.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TINZAPARIN. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does TINZAPARIN Cause?
Acute kidney injury (135)
Anaemia (118)
Off label use (110)
Maternal exposure during pregnancy (108)
Thrombocytopenia (86)
Drug ineffective (82)
Toxic epidermal necrolysis (80)
Hepatocellular injury (70)
Premature baby (70)
Cholestasis (67)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TINZAPARIN Alternatives Have Lower Interstitial lung disease Risk?
TINZAPARIN vs TIOCONAZOLE
TINZAPARIN vs TIOPRONIN
TINZAPARIN vs TIOTROPIUM
TINZAPARIN vs TIPIRACIL\TRIFLURIDINE
TINZAPARIN vs TIPRANAVIR